+++
title = "Moderna says RSV vaccine is 84% effective at preventing disease in older adults"
description = "RSV infections kill between 6,000 and 10,000 older adults every year and result in 60,000 to 120,000 hospitalizations, according to the CDC."
date = "2023-01-18 11:19:37"
slug = "63c7d5a85f72fd6dd5cf93ae"
image = "https://i.imgur.com/Y3DTPdf.jpg"
score = "782"
categories = ['respiratory', 'moderna', 'trial']
+++

RSV infections kill between 6,000 and 10,000 older adults every year and result in 60,000 to 120,000 hospitalizations, according to the CDC.

## Highlights

- Moderna says its vaccine that targets respiratory syncytial virus is effective at preventing disease in older adults.
- There currently is no FDA-approved vaccine for RSV.
- RSV infections kill between 6,000 and 10,000 older adults every year and result in 60,000 to 120,000 hospitalizations, the CDC says.
- The safety and efficacy data from the trial will be published in a peer-reviewed journal, the company says.
- Moderna plans to file an application for approval by the Food and Drug Administration in the first half of this year, according to the company.

---

{{< rawhtml >}}
  <p class="article-category">
    <a target="_blank" href="https://www.cnbc.com/2023/01/17/moderna-says-rsv-vaccine-is-84percent-effective-at-preventing-disease-in-older-adults.html">READ THE ORIGINAL ARTICLE</a>
  </p>
{{< /rawhtml >}}
